article
Dengue and dengue haemorrhagic fever
José G. Rigau-Péreza b✉, Gary G. Clarkb, Duane J. Gublerc, Paul Reiterb, Eduard Joachim Sandersb, A. Vance Vorndamb
- aDengue Branch, Division of Vector-borne Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico 00921-3200, USA. Jor1@cdc.gov
- bDengue Branch, San Juan, Puerto Rico CDC, Fort Collins, Colorado, USA
- cDivision of Vector-borne Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico CDC, Fort Collins, Colorado, USA)
- ✉Corresponding author
Looking for the full paper…
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
No abstract is available from our sources. Use “Read paper” to view it.
TL;DRThe geographical expansion of DHF presents the need for well-documented clinical, epidemiological, and virological descriptions of the syndrome in the Americas, and biological and social research are essential to develop effective mosquito control, medications to reduce capillary leakage, and a safe tetravalent vaccine. (Semantic Scholar)